CHRISTINA ODOM: Open Payments
NPI 1043940141 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$256 in 13 payments from 9 companies in 2025. Trend: 2023 $669 · 2024 $605 · 2025 $256
Food & beverage: $256
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| SANOFI-AVENTIS U.S. LLC | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Amgen Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Exact Sciences Corporation | 1 | $14 |
Products named: Ozempic, Kerendia, TZIELD, JARDIANCE, Korlym, SHINGRIX, OTEZLA, FARXIGA.
Industry payments across GA — which companies pay providers there.
